Richard Mortimer, Managing Principal, Analysis Group to Speak at The Knowledge Group's The BPCIA Patent Dance:What's Old and What's New in 2018

Top Quote The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Richard Mortimer, Managing Principal, Analysis Group will speak at The Knowledge Group’s webcast entitled: “The BPCIA Patent Dance: What’s Old and What’s New in 2018.” This event is scheduled for June 14, 2018 from 12:00 pm to 1:00 pm ET. End Quote
  • (1888PressRelease) June 05, 2018 - The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Richard Mortimer, Managing Principal, Analysis Group will speak at The Knowledge Group’s webcast entitled: “The BPCIA Patent Dance: What’s Old and What’s New in 2018.” This event is scheduled for June 14, 2018 from 12:00 pm to 1:00 pm ET.

    For further details, please visit: https://www.theknowledgegroup.org/webcasts/the-bpcia-patent-dance-2018/

    About Richard Mortimer
    Dr. Mortimer specializes in health economics, industrial organization, microeconomic theory, and econometrics. He has provided economic analyses in numerous matters involving questions of market power, pricing, and market exclusion and foreclosure. He has also provided analyses and expert testimony on behalf of health care clients related to litigation (including IP-related matters), and government investigations. In addition to his work in litigation, Dr. Mortimer has undertaken research in the area of health care policy, and has authored several public policy studies. These studies include the potential cost savings from passage of legislation developing an accelerated pathway for biosimilar entry, and the appropriate data exclusivity periods for biologics. His research has been published in leading peer-reviewed journals, including Health Affairs, Nature Reviews Drug Discovery, The Journal of Industrial Economics, and the Journal of Medical Economics.

    About Analysis Group

    Analysis Group is one of the largest economics consulting firms, with more than 850 professionals across 14 offices in North America, Europe, and Asia. Since 1981, we have provided expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune Global 500 companies, and government agencies worldwide. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional breadth and depth of expertise.

    Website: http://www.analysisgroup.com/

    Abstract
    In its recent Amgen v. Sandoz decision, the Federal Circuit has ruled that the innovators’ initiation of Biologics Price Competition and Innovation Act (BPCIA) pre-litigation information exchanges, known as “patent dance,” is unenforceable under state law. This is in addition to its June 2017 decision which held that patent dance cannot be enforced under the federal law, either. Thus, innovators seeking for biosimilar makers’ disclosures, may have no other option but to sue for infringement.

    Recent decisions, such as this, clearly impact the BPCIA litigation landscape. Biosimilar makers and innovator companies eyeing patent litigation should keep themselves abreast of key biosimilar developments in 2018 and beyond.

    In this LIVE Webcast, a panel of thought leaders and practitioners assembled by The Knowledge Group will discuss the fundamentals as well as updates regarding the latest and significant issues surrounding the BPCIA Patent Dance. Speakers will also give insights on practical BPCIA litigation strategies and the economic implications of patent protection from biosimilar competition as they delve into in-depth-analysis of recent court rulings in a rapidly evolving legal climate.

    Key topics include:
    • BPCIA Patent Dance: Recent Trends and Developments
    • Notable Court Rulings
    • Best Litigation Strategies in Light of Updates--To Dance or Not To Dance?
    • Economic Implications of Biologic Patents and Litigation Strategies
    • Outlook on Regulatory and Litigation Activities

    About The Knowledge Group/The Knowledge Congress Live Webcast Series

    The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information